Answer
COSOPT (dorzolamide/timolol) should be used cautiously in patients with spontaneous hypoglycaemia or labile diabetes because its systemically absorbed beta-blocker component, timolol, may mask the signs and symptoms of acute hypoglycaemia.
Sources for this answer
- COSOPT 20 mg/ml + 5 mg/ml, eye drops, solutionSanten UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 9Document updated
Sources checked